MHC class I antigen processing regulated by cytosolic proteolysis - Short cuts that alter peptide generation

Molecular Immunology

Volumn 39, Issue 3-4, 2002, Pages 171-179

  Kessler, Benedikt M ^a   Glas, Rickard ^b   Ploegh, Hidde L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cytosolic proteolysis; Cytotoxic T lymphocytes; MHC class I antigens; Oligopeptidases; Proteasome inhibitor; Tumor associated antigens

Indexed keywords

CYTOKINE; GAMMA INTERFERON; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEASOME; UBIQUITIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; TUMOR CELL;

ANIMALS; ANTIGEN PRESENTATION; CYSTEINE ENDOPEPTIDASES; CYTOSOL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIGANDS; MULTIENZYME COMPLEXES; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 0036776739     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00100-1     Document Type: Review

References (98)

1. Proteasome inhibition: A new strategy in cancer treatment
2. Peptide generation in the major histocompatibility complex class I antigen processing and presentation pathway
3. Use of proteasome inhibitors to examine processing of antigens for major histocompatibility complex class I presentation
4. The proteasome: Paradigm of a self-compartmentalizing protease
5. Impairment of the ubiquitin-proteasome system by protein aggregation
6. Allelic differences in the relationship between proteasome activity and MHC class I peptide loading
7. Interferon-γ can stimulate post-proteasomal trimming of the N-terminus of an antigenic peptide by inducing leucine aminopeptidase
8. Regulatory functions of ubiquitination in the immune system
9. Remarkable roles of proteolysis on and beyond the cell surface
10. Substrate binding and sequence preference of the proteasome revealed by active site-directed affinity probes
11. A novel active site-directed probe specific for deubiquitinating enzymes reveals proteasome association of USP14
12. 26S Proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide
13. + T cells at the levels of T cell repertoire and presentation of viral antigens
14. Ubiquitin-mediated proteolysis: Biological regulation via destruction
15. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide
16. Subtypes of 20S proteasomes from skeletal muscle
17. Inhibition of proteasomal degradation by the Gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal
18. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands
19. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum
20. MHC class I expression in mice lacking the proteasome subunit LMP7
21. Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines
22. Variations in proteasome subunit composition and enzymatic activity in B lymphoma lines and normal B cells
23. Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum
24. Antigen presentation by MHC class I and its regulation by interferon-γ
25. C-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells
26. A giant protease with potential to substitute for some functions of the proteasome
27. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin
28. Generation of MHC class I peptide antigens by protein processing in the secretory route by furin
29. A proteolytic system that compensates for loss of proteasome function
30. Adenovirus early region 1A protein binds to mammalian SUG1: A regulatory component of the proteasome
31. Selective proteasome inhibitors: Modulators of antigen presentation
32. A role for the proteasome regulator PA28α in antigen presentation
33. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome
34. Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why?
35. Mutations in the yeast proteasome β-type subunit Pre3 uncover position-dependent effects on proteasomal peptidase activity and in vivo function
36. Human T cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity
37. Proteasomes of the yeast S. cerevisiae: Genes, structure and functions
38. The proteasome and protein degradation in yeast
39. LMP2 expression and proteasome activity in NOD mice (in process citation)
40. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic β subunits
41. Immunoproteasomes largely replace constitutive proteasomes during an anti-viral and antibacterial immune response in the liver
42. Proteasome inhibitors: From research tools to drug candidates
43. Antigen processing by the proteasome
44. A role for a novel luminal endoplasmic reticulum aminopeptidase in final trimming of 26S proteasome-generated major histocompatability complex class I antigenic peptides
45. Substrate targeting in the ubiquitin system
46. Proteasome inhibitors: Valuable new tools for cell biologists
47. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen 1
48. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation
49. Sequential cleavage by metallo-peptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation
50. Differences in the expression of human MHC class I alleles and their associated peptides in the presence of proteasome inhibitors
51. Dendritic cells upregulate immunoproteasomes and the proteasome regulator PA28 during maturation
52. Escape of human solid tumors from T cell recognition: Molecular mechanisms and functional significance
53. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity
54. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
55. Immunoproteasome assembly and antigen presentation in mice lacking both PA28α and PA28β
56. The ubiquitin-proteasome pathway and proteasome inhibitors
57. Lack of proteasome active site allostery as revealed by subunit-specific inhibitors
58. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation
59. The specificity of proteasomes: Impact on MHC class I processing and presentation of antigens
60. Solid phase synthesis of peptide vinyl sulfone and peptide epoxyketone proteasome inhibitors
61. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells
62. -/- mice
63. Cells adapted to the proteasome inhibitor 4-hydroxy-5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival
64. Degradation of cell proteins and the generation of MHC class I-presented peptides
65. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
66. Effects on NF-κB1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome
67. Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase
68. Perfect use of imperfection
69. Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein
70. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or downregulate antigen presentation at nontoxic doses
71. The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition
72. HIV-1 Tat inhibits the 20S proteasome and its 11S regulator-mediated activation
73. Antigen processing machinery breakdown and tumor growth
74. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules
75. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: Implications for vaccine design
76. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes
77. Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation
78. *0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100
79. Trimming of antigenic peptides in an early secretory compartment
80. Quantitative aspects of T cell activation - Peptide generation and editing by MHC class I molecules
81. Two new proteases in the MHC class I processing pathway
82. Tricorn protease - The core of a modular proteolytic system
83. The role of tricorn protease and its aminopeptidase-interacting factors in cellular protein degradation
84. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products
85. Regulation of the 26S proteasome by adenovirus E1A
86. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3
87. Genes regulating MHC class I processing of antigen
88. Altered peptidase and viral-specific T cell response in LMP2 mutant mice
89. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: Involvement of non-proteasomal cytosolic proteases in antigen processing
90. The 26S proteasome: A molecular machine designed for controlled proteolysis
91. Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity
92. Structural basis for the activation of 20S proteasomes by 11S regulators
93. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
94. Not such a dismal science: The economics of protein synthesis, folding, degradation and antigen processing
95. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
96. Cut and trim: Generating MHC class I peptide ligands
97. Proteolysis and class I major histocompatibility complex antigen presentation